We are dedicated to developing cutting-edge fertility tools through continuous research and innovation. Our advanced tools empower clinics to assist families in realizing their dreams of parenthood. By integrating the latest scientific advancements, we ensure that our products lead the way in reproductive medicine. Our commitment to excellence transforms innovative ideas into tangible solutions. Together, we turn the rhythm of innovation into the heartbeat of new life.
Oocyte collection is a key procedure in assisted reproductive technologies (ART), designed to retrieve mature oocytes from the ovaries
Semen sample collection is carried out under strict laboratory protocols, with semen examination and processing typically following the WHO Laboratory Manual for the Examination and Processing of Human Semen
Selection of the insemination method—either Intracytoplasmic Sperm Injection (ICSI) or conventional In Vitro Fertilization (cIVF)—is based on semen examination and processing results and the patients’ prior IVF history.
Normally fertilized oocytes (zygotes) are cultured under oil for 2–5 days and assessed for quality either manually or using time-lapse imaging combined with artificial intelligence (AI) to select the best embryos for transfer.
The selected embryo(s) are transferred into the uterus using a thin, flexible and non-traumatic catheter, typically guided gently under ultrasound visualization to ensure precise placement in a simple, non-surgical procedure.
Vitrification and slow freezing are the two primary techniques used to cryopreserve embryos and oocytes in IVF. While both aim to prevent the formation of intracellular ice crystals, vitrification has emerged as the preferred method in modern clinical practice due to its superior effectiveness in achieving this goal.
Preimplantation genetic testing (PGT) screens embryos for genetic abnormalitiesbefore embryo transfer and implantation in IVF, aiming to increase healthy pregnancyrates and reduce the risk of inherited disorders.
